Average Co-Inventor Count = 5.82
ph-index = 17
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Abbott Laboratories Corporation (79 from 4,177 patents)
2. Global Blood Therapeutics, Inc. (5 from 57 patents)
3. Abbvie Inc. (3 from 822 patents)
4. Imago Pharmaceuticals, Inc. (3 from 5 patents)
5. Elan Pharmaceuticals, Inc. (1 from 202 patents)
6. Abbott Laboraotries (1 from 1 patent)
92 patents:
1. 11584734 - Tricyclic compounds as histone methyltransferase inhibitors
2. 11014884 - Modulators of hemoglobin
3. 10144746 - Bridged bicyclic kallikrein inhibitors
4. 9815853 - Bridged bicyclic kallikrein inhibitors
5. 9796706 - Inhibitors of Jun N-terminal kinase
6. 9695166 - Pyrazolopyridine pyrazolopyrimidine and related compounds
7. 9493485 - Spirocyclic dihydro-thiazine and dihydro-oxazine BACE inhibitors, and compositions and uses thereof
8. 9073891 - Inhibitors of Jun N-terminal kinase
9. 8748627 - Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome
10. 8735595 - Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome
11. 8637546 - Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DDP-IV)
12. 8450363 - Inhibitors of Jun N-terminal kinase
13. 8207350 - Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome
14. 8119664 - Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
15. 7968707 - Retroviral protease inhibiting compounds